NCT04161885: An ongoing trial by AbbVie
This trial is ongoing. It must report results 9 months, 1 week from now.
Full data
| Full entry on ClinicalTrials.gov | NCT04161885 |
|---|---|
| Title | A Randomized, Open Label Phase 3 Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine After Allogeneic Stem Cell Transplantation in Subjects With Acute Myeloid Leukemia (AML) (VIALE-T) |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Feb. 26, 2020 |
| Completion date | Sept. 23, 2025 |
| Required reporting date | Sept. 23, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |